Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-037342

EVP, Research & CSO sold 1,375 shares at $42.51 ($58,451)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-06-01 Option exercise +1,375 $1.53 $2,104 93,075 D
Virgin Herbert EVP, Research & CSO 2021-06-01 Sale −1,375 $42.51 $58,451 91,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2021-06-01 Option exercise · Stock Option (Right to Buy) −1,375 300,130 D
Open-market sales · 1,375 sh · avg $42.51 · $58,451
Loading xslF345X03/doc4.xml…